Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2024 Mar 11;35(2):102171. doi: 10.1016/j.omtn.2024.102171

The mRNACalc webserver accounts for the N1-methylpseudouridine hypochromicity to enable precise nucleoside-modified mRNA quantification

Esteban Finol 1,, Sarah E Krul 2,3, Sean J Hoehn 2,3, Xudong Lyu 1, Carlos E Crespo-Hernández 2,∗∗
PMCID: PMC10973171  PMID: 38549913

Abstract

Nucleoside-modified messenger RNA (mRNA) technologies necessarily incorporate N1-methylpseudouridine into the mRNA molecules to prevent the over-stimulation of cytoplasmic RNA sensors. Despite this modification, mRNA concentrations remain mostly determined through the measurement of UV absorbance at 260 nm wavelength (A260). Herein, we report that the N1-methylpseudouridine absorbs approximately 40% less UV light at 260 nm than uridine, and its incorporation into mRNAs leads to the under-estimation of nucleoside-modified mRNA concentrations, with 5%–15% error, in an mRNA-sequence-dependent manner. We therefore examined the RNA quantification methods and developed the mRNACalc webserver. It accounts for the molar absorption coefficient of modified nucleotides at 260 nm wavelength, the RNA composition of the mRNA, and the A260 of the mRNA sample to enable accurate quantification of nucleoside-modified mRNAs.

Keywords: MT: Bioinformatics, N1-methylpseudouridine, pseudouridine, modified-nucleoside, mRNA, UV absorption

Graphical abstract

graphic file with name fx1.jpg


Finol and colleagues observed that the N1-methylpseudouridine (m1Ψ), which is incorporated in mRNA technologies, absorbs approximately 40% less UV light than uridine, affecting the traditional methods for mRNA concentration determination. They revisited these methods and developed a software that corrects for the m1Ψ hypochromicity, thus enabling accurate nucleoside-modified mRNA quantification.

Introduction

The therapeutic use of messenger RNA (mRNA) has sparked great optimism in the development of novel vaccines and therapeutics against a myriad of infectious or as-yet-incurable diseases.1 The mRNA technology enables the production of antigenic, functional, and/or therapeutic proteins by introducing mRNA into the human body and cells.2 Since mRNAs act in the cytoplasm transiently, they do not bear any risk of integration into the host cell genome. Most importantly, the mRNA technology enables rapid, cost-efficient, and scalable production, which is free of cellular (cell cultures) or animal materials.3 Thus, mRNA technologies facilitate manufacturing and allow for a rapid response to emerging infectious diseases, as emphatically underscored by the rapid rollout of COVID-19 mRNA vaccines in many parts of the world. Modified nucleosides, such as pseudouridine (Ψ), N1-methylpseudouridine (m1Ψ), and 5-methylcytidine (m5C), are often incorporated into the mRNA molecules. Such modifications reduce stimulation of cytoplasmic RNA sensors, such as Toll-like receptors 3 and 7, for improved safety profiles and enhanced mRNA translation.4,5 However, how modified nucleosides affect mRNA concentration measurements and potentially confound preclinical dosing, efficacy, and toxicology studies, which could make or break further clinical development of any therapeutic, remains undefined.

The determination of RNA concentration often relies on measurements of its UV absorbance at 260 nm wavelength (A260) and the implementation of the Beer-Lambert law.6 The accuracy of these measurements is scattered by the variable hypochromicity of RNA due to its sequence-dependent folding. The molar absorption coefficient (MAC, or extinction coefficient [ε]) of a folded RNA at 260 nm (ε260) is reduced as compared to its unfolded state.7 This difference is buffer and concentration dependent and arises from changes in the chemical environment of the nucleobases—the main chromophore—due to base pairing, stacking, intermolecular interactions, and other conformational changes. Considering these variabilities, a rough estimation for the MAC260 of any single-stranded RNA (ssRNA), 40 μg/mL per absorbance unit, is extensively used, and its associated ±10%–20% error in the estimation of RNA concentration is widely accepted.6 This error range may suffice to assess dose response for mRNA therapeutics across several orders of magnitude in cellula or in in vivo experiments, yet it would be valuable to know concentrations at higher accuracy for the development of mRNA technologies. Our particular concern is in measurements of self-amplifying RNAs (saRNAs) and nucleoside-modified mRNAs. The logarithmic amplification of saRNA can convert a 20% accepted error in RNA concentration into several-fold differences in dose response between one experiment and subsequent replicates. The chemical modifications on the nucleobases of mRNA can also induce profound changes in the mRNA MAC hindering the accurate quantification of nucleoside-modified mRNA concentrations.

To attain greater accuracy in RNA quantification, RNA molecules are hydrolyzed prior to UV absorbance determination using a combination of thermal and alkaline hydrolysis.6,8 The RNA hydrolysis shifts the hypochromic folded state of the RNA to the hyperchromic state of the single monophosphate nucleotides.9 Since the precise MAC of the four standard nucleotides in aqueous buffered solution is known, the molar absorption of any hydrolyzed mRNA can be calculated as the sum of the molar absorption of its nucleotide compositions. Thus, upon the A260 determination, the RNA concentration can be quantified with an error of ∼4% using these methods.6 The incorporation of modified nucleosides can alter the RNA molar absorption and increase the error of the measurements in an RNA-sequence-dependent manner. Other non-UV-spectroscopic methods relying on the unspecific RNA binding of fluorophores for the determination of RNA concentration may help to overcome any change in the MAC of modified nucleoside mRNA. However, the impact of RNA modifications on the binding affinity of these fluorophores also remains unknown.

Herein, we report our effort to revisit and determine the MAC of modified nucleosides (Ψ, m1Ψ, and m5C). We also examined three different methods for RNA hydrolysis and provided them along with the mRNACalc webserver. This web tool incorporates the most recently revised MAC260 for standard, modified, and mRNA capping nucleosides, allowing the accurate determination of standard and nucleoside-modified mRNAs using UV spectroscopy.

Results

To assess the impact of chemical modifications on the spectrophotometric parameters of pyrimidine nucleosides for mRNA quantification, we determined and compared the molar UV absorption curves of standard nucleosides (U and C) and the modified nucleosides that have recently been employed in nucleoside-modified mRNA technologies (Ψ, m1Ψ, and m5C). For the cytidine-to-m5C comparisons, a shift of +7 nm in the peak maximum (Δλmax) was observed with a 20.8% reduction in the ε260 for the m5C nucleoside (Figures 1A and 1B). For the Ψ and m1Ψ curves, a similar shift was detected (Δλmax = +9 nm in m1Ψ; Figure 1C), with a reduced molar absorption at 260 nm for m1Ψ (Δε260 = −22.8%). More importantly, m1Ψ is hypochromic as compared to uridine at λmax (Δεmax = −21%), and, due to the λmax shift, m1Ψ absorbs 39.8% less than uridine at 260 nm (Figure 1D), suggesting that m1Ψ-incorporated mRNAs can have reduced MACs.

Figure 1.

Figure 1

The nucleobase methylation and its bathochromic effect on the UV molar absorption spectra of pyrimidines

(A) Skeletal formula of uridine, thymidine, cytidine, 5-methylcytidine, pseudouridine, and N1-methylpseudouridine. The methyl substituents are highlighted in red. These λmax, εmax, and ε260 values are implemented in the mRNACalc webserver. The source of these values is provided in the supplemental information. (B) Steady-state absorption spectra of cytidine (black line) and 5-methylcytidine (red line) at pH 7.4. (C) Steady-state absorption spectra of pseudouridine (orange line) and N1-methylpseudouridine (green line) at pH 7.4. (D) Steady-state absorption spectra of uridine (light blue line) and N1-methylpseudouridine (green line) at pH 7.4. The ε260 for U and m1Ψ are shown.

To assess whether the complete U-to-m1Ψ substitution alters the UV absorbance of an mRNA, the same mRNA was transcribed using either U, Ψ, or m1Ψ. These mRNAs also encoded a dimeric-Broccoli (dBroc) aptamer in their 3′ untranslated regions (UTRs) (Figure 2A). Once the DFHBI-1T fluorophore was bound to the G-quadruplex in the Broccoli aptamer, the mRNA emitted green light upon excitation.10 We also confirmed that the brightness, melting point, and affinity of the DFHBI-1T-Broccoli complex are not significantly perturbed by the U-to-Ψ or U-to-m1Ψ substitution (Table S1; Figure S1). After normalizing the UV absorbance (A260) of each mRNA by its corresponding fluorescence (F507), it was observed that, in practice, the relative UV absorbance of the nucleoside-modified mRNA was significantly reduced as compared to the standard mRNA (ΔΑ260 = −10.6%; Figures 2B and 2C). This hypochromicity was also independently observed in two additional mRNAs with either higher or lower m1Ψ composition (ΔΑ260 = −11.8% and −6.7%, respectively, in Figure 2C). These findings confirmed that m1Ψ-mRNAs are hypochromic and their hypochromicity is dependent on the nucleoside composition. To correct for the observed hypochromicity in nucleoside-modified mRNA, we built the mRNACalc software, which calculates the expected MAC260 of a hydrolyzed mRNA. It considers its nucleotide composition and the MAC of standard and modified nucleosides, including the nucleosides in the mRNA cap (documentation in the supplemental information and Tables S2–S6). We used this software to predict MAC260 for the different U-, Ψ-, and m1Ψ-dBroc-mRNAs in Figure 2C and plotted their Ψ-/U-mRNA and m1Ψ-/U-mRNA MAC260 ratios against the experimentally determined normalized A260/F507 ratio (Figure 2D). The observed linearity in this graph corresponds to the expected linearity in the Beer-Lambert law for standard and modified nucleosides and its implementation in ssRNAs, such as mRNA.

Figure 2.

Figure 2

The hypochromicity of nucleoside-modified mRNA can be predicted from their nucleoside composition

(A) Schematic representation of the mRNAs that were designed to determine the normalized A260/F507 values. (B) Relative UV absorption curves from mRNAs with uridine or N1-methylpseudouridine nucleosides. They were normalized to the corresponding F507 values and plotted relative to the peak maximum of the U-mRNA. (C) The normalized A260/F507 values from five replicates of the U-, Ψ-, and m1Ψ-mRNAs are shown for dBroc-mRNA1. Similar measurements in two additional U- and m1Ψ-mRNAs are shown. The black lines correspond to the average absorbance. Values are relative to the average absorbance of the U-mRNA. All comparisons of the mean relative A260/F507 values were significant (t test; p < 0.005). (D) The normalized A260/F507 values in (C) were plotted against their predicted hypochromicity using the mRNACalc software.

To enable accurate measurement of nucleoside-modified mRNA, we also assessed different RNA hydrolysis methods. The modern analytical use of alkaline hydrolysis of RNA has been known since 1922, when Steudel and Peiser demonstrated that 1 M NaOH hydrolyzed yeast RNA whereas thymus DNA resisted the NaOH hydrolysis.11 The alkali-promoted transesterification of RNA occurs due to the nucleophilic attack of the 2′-OH in the ribose to the 3′,5′-phosphodiester bond, explaining the alkali resistance of the 2′-deoxyribonucleotides (Figure 3A).12 This reaction is further catalyzed with the introduction of heat. However, the combination of thermal and alkaline hydrolysis, e.g., 1 M NaOH at 95°C, also catalyzes the deamination of cytosine to uridine in a small percentage of residues.13,14 Thus, a compromise between the two methods is often applied. In our hands, three of such protocols showed a similar increase in A260 upon hydrolysis of yeast RNA—a historical standard sample for these methods (Figure 3B). One of these methods (0.8 M NaOH at 37°C) was also applied on U- and m1Ψ-mRNAs (Figure 3C), and the use of RNA hydrolysis indeed increased the A260 of both types of mRNA, confirming the importance of performing RNA hydrolysis to remove the effect of RNA folding on the mRNA UV absorption and therefore allow a more accurate determination of mRNA concentrations. We also applied the RNA hydrolysis methods on U- and m1Ψ-mRNAs and determined their concentration by measuring their A260 and using the mRNACalc software to correct for hypochromicity. The concentration of these mRNAs was then reassessed by performing direct A260 measurements, without prior RNA hydrolysis and implementing the extensively used MAC260 for ssRNA (40 μg/mL per absorbance unit), or by using a commercially available fluorescence-based assay. We could observe that both methods differentially estimated the nucleoside-modified and standard mRNA concentrations, with an underestimation of the m1Ψ-mRNA concentration (Figure S2).

Figure 3.

Figure 3

RNA hydrolysis is essential for the determination of mRNA concentrations

(A) Alkali-promoted transesterification allows RNA hydrolysis and mRNA quantification. Under alkaline conditions, the reactive -OH triggers the nucleophilic attack of the 2′-OH on the 3′,5′-phosphodiester linkage, converting the ground-state configuration of RNA into a penta-coordinated intermediate and leading to a 2′3′-cyclic phosphodiester. This cyclic form is then known to form 3′ and 2′ monophosphate nucleotides (data not shown). (B) Thermal and/or alkaline hydrolysis of RNA over time. Yeast RNA was hydrolyzed using three different previously described methods and the ΔA260 was determined using a UV spectrophotometer at different intervals. For expedited RNA hydrolysis (1 or 2 h incubation), a combination of thermal and alkaline hydrolyses can be used (dark blue dots, 0.8 M NaOH at 37°C; red dots, 0.5 M Na2CO3 [pH 8] at 95°C). For overnight incubation, alkaline hydrolysis suffices (light blue dots, 0.8 M NaOH at 20°C, the last four measurements were performed after an overnight incubation). Dots indicate the mean value of three measurements. Error bars correspond to standard deviations. (C) Hydrolysis of U-mRNA and m1Ψ-mRNA using 0.8 M NaOH at 37°C increases the UV absorption of mRNA. This mRNA corresponds to dBroc-mRNA3 in (C). A260 values are normalized to the mean A260 values of the non-hydrolyzed U-mRNA.

Discussion

Ψ is an isomer of uridine—the standard nucleoside in RNA. Ψ, as opposed to other nucleosides, is a carbon-carbon ribofuranosyl nucleoside, i.e., the uracil nucleobase is linked to the ribose through its fifth carbon instead of an N1 linkage.15 This unique arrangement places the N1 imino group toward the so-called “C-H” edge of the pyrimidine ring and confers additional properties to this edge in Ψ. This imino hydrogen proton is susceptible to hydrogen bonding, chemical exchange, and chemical modifications such as N1 methylation. Thus, the m1Ψ, as well as the m5C, represents a modification of the C-H edge of the pyrimidine nucleobase. The influence of a 5-methyl substituent on the UV molar absorption of pyrimidine rings has been well known since the 1940s, when Sister Miriam Michael Stimson showed that a similar 5-methyl modification also differentiates uridine from thymidine and provokes a subtle reduction in molar absorbance (ΔMACmax = −3%) and a shift of the peak maximum (Δλmax = +5 nm) to a longer wavelength—a bathochromic shift.16,17,18,19 In combination, these two effects provoke a substantial MAC260 reduction for the thymidine nucleoside (ΔMAC260 = −11.4%). In our study, similar differences were observed for the C-to-m5C and Ψ-to-m1Ψ comparisons, with a more pronounced MAC260 difference for the U-to-m1Ψ comparison. Thus, the substitution of uridine by m1Ψ in mRNA technologies can substantially modify the spectrophotometric properties of the mRNA.

In principle, the modified nucleosides may also promote mRNA folding and reduce its UV absorption. This is particularly relevant for the Ψ modification. Its N1 hydrogen can engage in additional hydrogen bonds, promoting and stabilizing RNA folding. For instance, the U-to-Ψ substitution in tRNA stabilizes the folded structure that is essential for translation.20 However, the m1Ψ nucleobase lacks this additional hydrogen bonding capability, and it is expected to have little or no effect on the RNA folding of less structured RNA molecules such as mRNAs. Considering that both Ψ- and m1Ψ-mRNAs followed the anticipated hypochromicity that is associated with the modified nucleosides’ hypochromicity at 260 nm wavelength (Figure 1) and their abundance in the mRNA (Figure 2C), rather than the expected distinct contribution of Ψ and m1Ψ to RNA folding, we can conclude that the observed reduction in the UV absorption of nucleoside-modified mRNA is mainly determined by the nucleobase composition and the intrinsic MAC of the nucleosides in the purified mRNAs. Importantly, the UV absorption spectrum of the m1Ψ-mRNA also depicted a broad absorption peak and a bathochromic shift, which brings about additional implications for the assessment of the RNA sample purity (Figure 2B; supplemental information). These findings indicate that for accurate determination of nucleoside-modified mRNA concentrations and proper interpretation of dose-ranging preclinical studies, the reported UV spectroscopic differences must be accounted for. Otherwise, nucleoside-modified mRNA concentrations may be underestimated by 5%–15% depending on the proportion of m1Ψ in the mRNA composition.

Considering that traditional methods underestimate the nucleoside-modified mRNA concentrations and to ease the implementation of the reported UV absorption parameters, we provide the mRNACalc software as an open-source webserver to calculate the MAC260 for nucleoside-modified mRNAs. It accounts for the hypochromicity of modified nucleosides as well as for the nucleoside composition of the mRNA, including the mRNA cap. Once the RNA sequence, the A260, and the RNA stock volume values are provided as input, the mRNACalc webserver calculates the RNA stock concentration in nM and ng/μL and the total RNA mass in μmole and μg. The webserver also includes the revisited experimental protocols and a workflow that implements a linear regression model from multiple measurements at serial dilutions (Figure 4). This workflow aims at reducing the impact of sample handling variation. Hence, the mRNACalc webserver represents a freely available and all-inclusive tool for the determination of nucleoside-modified mRNA concentrations using UV spectroscopy.

Figure 4.

Figure 4

Experimental workflow for the determination of RNA concentration using the mRNACalc webserver

The colored dots refer to the different RNA hydrolysis methods in Figure 3B.

Materials and methods

The Beer-Lambert experiments

Ψ (≥98% purity), m5C (≥99% purity), cytidine (99% purity), and uridine (99% purity) were purchased from Sigma-Aldrich. m1Ψ (>95% purity) was purchased from Biosynth Carbosynth. They were used as received. Phosphate buffer solutions with a total phosphate concentration of 16 mM from monosodium and disodium phosphate salts dissociated in ultrapure water (Millipore) were freshly prepared on the day of each experiment. The pH of the solution was adjusted using 0.1 M solutions of NaOH and HCl to the desired pH of 7.4 (±0.1 pH units). Steady-state absorption was recorded using a Cary 100 spectrometer. Serial dilutions of known concentration were carried out such that the absorbance reading at the respective lambda maximum (local maximum absorbance) remained below 1.0, within the linear range of the instrument. The MACs were experimentally determined using the slope from the linear regression from plotting absorbance versus concentration. The correlation constant for the linear regression analysis of the Beer-Lambert’s law data for determining molar absorption constants was >0.9999, showing a strong linear relationship.

mRNA in vitro transcription and purification

The plasmid DNA template (pUCIDT plasmid) was grown in DH5 alpha E. coli (New England Biolabs) in 300 mL Luria-Bertani broth supplemented with kanamycin (50 μg/mL), and a maxi preparation was performed using the QIAGEN Plasmid Plus Maxi Kit following manufacturer instructions. The plasmid encoded a T7 promoter followed by the mCherry gene with a degradation tag (1,449 nucleotides) plus the 3′ and 5′ UTRs of the BNT162b2 mRNA vaccine (541 nucleotides). The double broccoli aptamer was encoded within the poly-adenine region in the 3′ UTR. The plasmid was linearized by EcoRV restriction enzyme digestion at the end of the 3′ UTR.

A standard T7 transcription reaction included 30 mM Tris-HCl (pH 7.9), 2 mM spermidine, 30 mM MgCl2, 5 mM NaCl, 10 mM DTT, 50 μg/mL BSA (New England Biolabs), 0.005% Triton X-100, 2% polyethylene glycol (PEG8000), 5 mM of each triphosphate ribonucleotide (standard nucleotides were purchased from Jena Bioscience GmBH and Ψ and m1Ψ from BOC Sciences), 2 μM linearized plasmid DNA template, 3.5 μM T7 RNA polymerase (in-house produced and purified), and 0.0025 units of E. coli inorganic PPase (New England Biolabs). All reagents were purchased from Sigma-Aldrich unless otherwise stated. The reactions were incubated at 37°C for 2.5 h and stopped by the addition of 500 mM EDTA (pH 8) to a final concentration of 35 mM.

The mRNA was purified using anion-exchange chromatography. A PRP-X600 anion-exchange column (Hamilton Company) was equilibrated in buffer A (85:15 100 mM Tris [pH 8]/acetonitrile). RNA samples were loaded onto the column at a flow rate of 3 mL/min and eluted with a 40 min gradient of 0%–40% buffer B (85:15 100 mM Tris, 2.5 M LiCl [pH 8]/acetonitrile). Fractions containing the mRNA were collected, and the mRNA molecules were precipitated using standard butanol extraction.21 The purity of the mRNA preparation was assessed using high-resolution automated electrophoresis in the Agilent 2100 Bioanalyzer system using the Bioanalyzer RNA 6000 pico assay (Agilent Technologies).

Determination of the mRNA UV absorption spectrum

To determine the UV absorption spectrum of mRNAs, the mRNA stocks were diluted to approximately 25 nM into a buffer containing 40 mM HEPES (pH 7.4), 5 mM MgCl2, and 100 mM KCl to a final volume of 2 mL. Five independent mRNA samples were prepared per mRNA set (U-, Ψ-, and m1Ψ-mRNAs). The UV absorption spectra were recorded for each mRNA sample using a UV-3600i plus UV-visible (UV-vis) spectrophotometer (Shimadzu Corp.).

Excitation-emission experiments on the DFHBI-1T-bound mRNAs

After UV absorption determination, the mRNA samples were bound to the DFHBI-1T fluorophore by adding 100 μM DFHBI-1T and 100% DMSO to a 500 nM concentration into the 2 mL mRNA samples. Fluorescence was measured with a Fluorolog-3 spectrofluorometer (Horiba Scientific) using the excitation and emission wavelengths commonly used for DFHBI-1T (excitation: 472 nm, emission: 507 nm).10

Determination of the relative UV absorbance (A260)

The A260/F507 ratios were calculated for each mRNA sample. The mean A260/F507 values for U-, Ψ-, and m1Ψ-mRNAs were calculated. The A260/F507 values of each sample were normalized using the mean A260/F507 value from the U-mRNA as reference, and they were plotted in a dot plot. The t tests were applied to compare the mean A260/F507 values across each pair of mRNA sets using a p value of 0.005 as the cutoff of significance.

Methods of RNA hydrolysis

Two methods of RNA hydrolysis were tested in this study. Torula yeast RNA was used as standard RNA sample (Sigma-Aldrich). The yeast RNA stock was prepared at 1,000 μg/μL in water. Thus, after 1/25 dilution, the UV absorbance of this RNA sample would be within the linear range of the instrument (UV-3600i plus UV-vis spectrophotometer, Shimadzu Corp.).

The most extensively used alkaline RNA hydrolysis method involves adding 1 part RNA and 4 parts 1 M NaOH and incubating them at 37°C for 1 h.22 To test this method, twelve yeast RNA samples were hydrolyzed. Every 10 min, a sample was neutralized with 4 parts 1 M HCl and diluted to 1/25 with 16 parts water. Three UV absorbance measurements were performed on every sample. Similarly, a room temperature variation of this method is often used for overnight RNA hydrolysis. Therefore, twelve RNA samples were hydrolyzed and incubated at 20°C for up to 15 h. Samples were neutralized and diluted hourly followed by three UV absorbance measurements.

A second method of thermal hydrolysis at neutral pH was also tested.8 To test this method, twelve yeast RNA samples hydrolyzed (1 part RNA in 9 parts 60 mM Na2CO3 [pH 8]) with an incubation of at 95°C for up to 2 h. Every 20 min, a sample was diluted to 1/25 with 15 parts water, and three UV absorption measurements were performed on every sample.

Data and code availability

The data that support the findings of this study are available from the corresponding author upon reasonable request. The webserver is available at https://www.mrnacalc.com. The website is free and open to all users, and there is no login requirement. The HTML script for the mRNACalc webserver is available under a GNU general public license from https://github.com/estebanfbfc/mRNACalc. It can be downloaded free of charge and run locally without internet access.

Acknowledgments

The authors would also like to thank Prof. Eng Eong Ooi for his invaluable advice and generosity throughout this work and Prof. Guillermo C. Bazan for providing access to the UV-vis and fluorescence spectrometers in his laboratory. This work was supported by the National Medical Research Council of Singapore through an Open Fund - Large Collaborative Grant, granted to Prof. Eng Eong Ooi, and by the National Science Foundation (grant no. CHE-2246805), granted to C.E.C-H.

Author contributions

E.F. conceived the study. E.F. and C.E.C.-H. supervised the project. E.F. developed the mRNACalc webserver. S.E.K. and S.J.H. performed the Beer-Lambert experiments and prepared the corresponding figure panel. E.F. and X.L. performed the relative absorbance of mRNA experiments and analyzed the data. E.F. prepared figures, wrote the initial draft of the manuscript, and edited the submitted version of the manuscript with contributions from all the authors.

Declaration of interests

The authors declare no competing interests.

Footnotes

Supplemental information can be found online at https://doi.org/10.1016/j.omtn.2024.102171.

Contributor Information

Esteban Finol, Email: esteban.finol@duke-nus.edu.sg.

Carlos E. Crespo-Hernández, Email: carlos.crespo@case.edu.

Supplemental information

Document S1. Supplemental materials and methods, Tables S1–S6, Figures S1, and S2
mmc1.pdf (449.7KB, pdf)
Document S2. Article plus supplemental information
mmc2.pdf (2.4MB, pdf)

References

  • 1.Chaudhary N., Weissman D., Whitehead K.A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 2021;20:817–838. doi: 10.1038/s41573-021-00283-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sahin U., Karikó K., Türeci Ö. mRNA-based therapeutics — developing a new class of drugs. Nat. Rev. Drug Discov. 2014;13:759–780. doi: 10.1038/nrd4278. [DOI] [PubMed] [Google Scholar]
  • 3.Webb C., Ip S., Bathula N.V., Popova P., Soriano S.K.V., Ly H.H., Eryilmaz B., Nguyen Huu V.A., Broadhead R., Rabel M., et al. Current Status and Future Perspectives on MRNA Drug Manufacturing. Mol. Pharm. 2022;19:1047–1058. doi: 10.1021/acs.molpharmaceut.2c00010. [DOI] [PubMed] [Google Scholar]
  • 4.Karikó K., Muramatsu H., Welsh F.A., Ludwig J., Kato H., Akira S., Weissman D. Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability. Mol. Ther. 2008;16:1833–1840. doi: 10.1038/mt.2008.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Andries O., Mc Cafferty S., De Smedt S.C., Weiss R., Sanders N.N., Kitada T. N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J. Control. Release. 2015;217:337–344. doi: 10.1016/j.jconrel.2015.08.051. [DOI] [PubMed] [Google Scholar]
  • 6.Cavaluzzi M.J., Borer P.N. Revised UV extinction coefficients for nucleoside-5′-monophosphates and unpaired DNA and RNA. Nucleic Acids Res. 2004;32:e13. doi: 10.1093/nar/gnh015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Tinoco I., Jr. Hypochromism in Polynucleotides. J. Am. Chem. Soc. 1960;82:4785–4790. doi: 10.1021/ja01503a007. [DOI] [Google Scholar]
  • 8.Wilson S.C., Cohen D.T., Wang X.C., Hammond M.C. A neutral pH thermal hydrolysis method for quantification of structured RNAs. RNA. 2014;20:1153–1160. doi: 10.1261/rna.045856.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Doty P., Boedtker H., Fresco J.R., Haselkorn R., Litt M. Secondary structure in ribonucleic acids. Proc. Natl. Acad. Sci. USA. 1959;45:482–499. doi: 10.1073/pnas.45.4.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Filonov G.S., Moon J.D., Svensen N., Jaffrey S.R. Broccoli: Rapid Selection of an RNA Mimic of Green Fluorescent Protein by Fluorescence-Based Selection and Directed Evolution. J. Am. Chem. Soc. 2014;136:16299–16308. doi: 10.1021/ja508478x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Steudel H., Peiser E. Über Nucleinsäure-Eiweißverbindungen. Bio. Chem. 1922;122:298–306. doi: 10.1515/bchm2.1922.122.4-6.298. [DOI] [Google Scholar]
  • 12.Lipkin D., Talbert P.T., Cohn M. The Mechanism of the Alkaline Hydrolysis of Ribonucleic Acids. J. Am. Chem. Soc. 1954;76:2871–2872. doi: 10.1021/ja01640a004. [DOI] [Google Scholar]
  • 13.Wang R.Y., Kuo K.C., Gehrke C.W., Huang L.-H., Ehrlich M. Heat- and alkali-induced deamination of 5-methylcytosine and cytosine residues in DNA. Biochim. Biophys. Acta. 1982;697:371–377. doi: 10.1016/0167-4781(82)90101-4. [DOI] [PubMed] [Google Scholar]
  • 14.Shen J.C., Rideout W.M., Jones P.A. The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Res. 1994;22:972–976. doi: 10.1093/nar/22.6.972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Cohn W.E. Pseudouridine, a Carbon-Carbon Linked Ribonucleoside in Ribonucleic Acids: Isolation, Structure, and Chemical Characteristics. J. Biol. Chem. 1960;235:1488–1498. doi: 10.1016/S0021-9258(18)69432-3. [DOI] [PubMed] [Google Scholar]
  • 16.Stimson M.M. The Ultraviolet Absorption Spectra of Some Pyrimidines. Chemical Structure and the Effect of pH on the Position of λmax. J. Am. Chem. Soc. 1949;71:1470–1474. doi: 10.1021/ja01172a093. [DOI] [PubMed] [Google Scholar]
  • 17.Sharonov A., Gustavsson T., Marguet S., Markovitsi D. Photophysical properties of 5-methylcytidine. Photochem. Photobiol. Sci. 2003;2:362–364. doi: 10.1039/b212664h. [DOI] [PubMed] [Google Scholar]
  • 18.Shugar D., Fox J.J. Spectrophotometric studies of nucleic acid derivatives and related compounds as a function of pH: I. Pyrimidines. Biochim. Biophys. Acta. 1952;9:199–218. doi: 10.1016/0006-3002(52)90147-9. [DOI] [PubMed] [Google Scholar]
  • 19.Rabczenko A., Shugar D. Studies on the conformation of nucleosides, dinucleoside monophosphates and homopolynucleotides containing uracil or thymine base residues, and ribose, deoxyribose or 2’-O-methylribose. Acta Biochim. Pol. 1971;18:387–402. [PubMed] [Google Scholar]
  • 20.Lorenz C., Lünse C.E., Mörl M. tRNA Modifications: Impact on Structure and Thermal Adaptation. Biomolecules. 2017;7:35. doi: 10.3390/biom7020035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Green M.R., Sambrook J. Concentrating Nucleic Acids by Extraction with Butanol. Cold Spring Harb. Protoc. 2017;2017 doi: 10.1101/pdb.prot093401. pdb.prot093401. [DOI] [PubMed] [Google Scholar]
  • 22.Bock R.M. Methods in Enzymology Nucleic Acids, Part A. Academic Press; 1967. [29] Alkaline hydrolysis of RNA; pp. 224–228. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Document S1. Supplemental materials and methods, Tables S1–S6, Figures S1, and S2
mmc1.pdf (449.7KB, pdf)
Document S2. Article plus supplemental information
mmc2.pdf (2.4MB, pdf)

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request. The webserver is available at https://www.mrnacalc.com. The website is free and open to all users, and there is no login requirement. The HTML script for the mRNACalc webserver is available under a GNU general public license from https://github.com/estebanfbfc/mRNACalc. It can be downloaded free of charge and run locally without internet access.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES